Literature DB >> 19589941

Hereditary hemochromatosis due to resistance to hepcidin: high hepcidin concentrations in a family with C326S ferroportin mutation.

Ronald L Sham, Pradyumna D Phatak, Elizabeta Nemeth, Tomas Ganz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19589941      PMCID： PMC2714220          DOI： 10.1182/blood-2009-04-216226

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  11 in total

Review 1.  Molecular control of iron transport.

Authors:  Tomas Ganz
Journal:  J Am Soc Nephrol       Date:  2007-01-17       Impact factor: 10.121

2.  Autosomal dominant hereditary hemochromatosis associated with a novel ferroportin mutation and unique clinical features.

Authors:  Ronald L Sham; Pradyumna D Phatak; Carol West; Pauline Lee; Caroline Andrews; Ernest Beutler
Journal:  Blood Cells Mol Dis       Date:  2005 Mar-Apr       Impact factor: 3.039

3.  Resistance to hepcidin is conferred by hemochromatosis-associated mutations of ferroportin.

Authors:  Hal Drakesmith; Lisa M Schimanski; Emma Ormerod; Alison T Merryweather-Clarke; Vip Viprakasit; Jon P Edwards; Emma Sweetland; Judy M Bastin; Diana Cowley; Yingyong Chinthammitr; Kathryn J H Robson; Alain R M Townsend
Journal:  Blood       Date:  2005-04-14       Impact factor: 22.113

4.  The iron exporter ferroportin/Slc40a1 is essential for iron homeostasis.

Authors:  Adriana Donovan; Christine A Lima; Jack L Pinkus; Geraldine S Pinkus; Leonard I Zon; Sylvie Robine; Nancy C Andrews
Journal:  Cell Metab       Date:  2005-03       Impact factor: 27.287

5.  Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization.

Authors:  Elizabeta Nemeth; Marie S Tuttle; Julie Powelson; Michael B Vaughn; Adriana Donovan; Diane McVey Ward; Tomas Ganz; Jerry Kaplan
Journal:  Science       Date:  2004-10-28       Impact factor: 47.728

6.  The molecular basis of hepcidin-resistant hereditary hemochromatosis.

Authors:  Augustine Fernandes; Gloria C Preza; Yen Phung; Ivana De Domenico; Jerry Kaplan; Tomas Ganz; Elizabeta Nemeth
Journal:  Blood       Date:  2009-04-21       Impact factor: 22.113

7.  Immunoassay for human serum hepcidin.

Authors:  Tomas Ganz; Gordana Olbina; Domenico Girelli; Elizabeta Nemeth; Mark Westerman
Journal:  Blood       Date:  2008-08-08       Impact factor: 22.113

Review 8.  The ferroportin disease.

Authors:  Antonello Pietrangelo
Journal:  Blood Cells Mol Dis       Date:  2004 Jan-Feb       Impact factor: 3.039

9.  Mutations in HFE2 cause iron overload in chromosome 1q-linked juvenile hemochromatosis.

Authors:  George Papanikolaou; Mark E Samuels; Erwin H Ludwig; Marcia L E MacDonald; Patrick L Franchini; Marie-Pierre Dubé; Lisa Andres; Julie MacFarlane; Nikos Sakellaropoulos; Marianna Politou; Elizabeta Nemeth; Jay Thompson; Jenni K Risler; Catherine Zaborowska; Ryan Babakaiff; Christopher C Radomski; Terry D Pape; Owen Davidas; John Christakis; Pierre Brissot; Gillian Lockitch; Tomas Ganz; Michael R Hayden; Y Paul Goldberg
Journal:  Nat Genet       Date:  2003-11-30       Impact factor: 38.330

10.  Hepcidin is decreased in TFR2 hemochromatosis.

Authors:  Elizabeta Nemeth; Antonella Roetto; Giovanni Garozzo; Tomas Ganz; Clara Camaschella
Journal:  Blood       Date:  2004-10-14       Impact factor: 22.113
View more
  26 in total

Review 1.  The long history of iron in the Universe and in health and disease.

Authors:  Alex D Sheftel; Anne B Mason; Prem Ponka
Journal:  Biochim Biophys Acta       Date:  2011-08-09

2.  Assessment of iron deficiency.

Authors:  Chaim Hershko
Journal:  Haematologica       Date:  2018-11-30       Impact factor: 9.941

3.  Rapid removal of phagosomal ferroportin in macrophages contributes to nutritional immunity.

Authors:  Ronald S Flannagan; Tayler J Farrell; Steven M Trothen; Jimmy D Dikeakos; David E Heinrichs
Journal:  Blood Adv       Date:  2021-01-26

4.  Detection of a rare mutation in the ferroportin gene through targeted next generation sequencing.

Authors:  Ludovica Ferbo; Paola M Manzini; Sadaf Badar; Natascia Campostrini; Alberto Ferrarini; Massimo Delledonne; Tiziana Francisci; Valter Tassi; Adriano Valfrè; Anna M Dall'omo; Sergio D'antico; Domenico Girelli; Antonella Roetto; Marco De Gobbi
Journal:  Blood Transfus       Date:  2016-04-28       Impact factor: 3.443

Review 5.  Hepcidin and iron regulation, 10 years later.

Authors:  Tomas Ganz
Journal:  Blood       Date:  2011-02-23       Impact factor: 22.113

6.  Minihepcidins are rationally designed small peptides that mimic hepcidin activity in mice and may be useful for the treatment of iron overload.

Authors:  Gloria C Preza; Piotr Ruchala; Rogelio Pinon; Emilio Ramos; Bo Qiao; Michael A Peralta; Shantanu Sharma; Alan Waring; Tomas Ganz; Elizabeta Nemeth
Journal:  J Clin Invest       Date:  2011-12       Impact factor: 14.808

Review 7.  Iron metabolism: interactions with normal and disordered erythropoiesis.

Authors:  Tomas Ganz; Elizabeta Nemeth
Journal:  Cold Spring Harb Perspect Med       Date:  2012-05       Impact factor: 6.915

Review 8.  A systems biology approach to iron metabolism.

Authors:  Julia Chifman; Reinhard Laubenbacher; Suzy V Torti
Journal:  Adv Exp Med Biol       Date:  2014       Impact factor: 2.622

9.  The molecular basis of hepcidin-resistant hereditary hemochromatosis.

Authors:  Augustine Fernandes; Gloria C Preza; Yen Phung; Ivana De Domenico; Jerry Kaplan; Tomas Ganz; Elizabeta Nemeth
Journal:  Blood       Date:  2009-04-21       Impact factor: 22.113

Review 10.  Iron deficiency anemia in celiac disease.

Authors:  Hugh James Freeman
Journal:  World J Gastroenterol       Date:  2015-08-21       Impact factor: 5.742
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.